Most Routine Blood Tests Don't Require 8 Hours of Fasting, Large Study Finds
A study of 100,000+ patients shows fasting matters for glucose and a few other tests, but most lab values are unaffected by fasting duration.
Summary
A large observational study published in JAMA Internal Medicine challenges the blanket 8-hour fasting rule before blood tests. Researchers analyzed paired blood draws from over 100,000 patients and found that out of 372 lab test items, only a handful showed clinically meaningful differences based on fasting duration. Glucose, triglycerides, gamma-glutamyl transferase, and lipase were the main exceptions, with glucose rising notably with shorter fasts. For most other tests, fasting duration had minimal impact. The findings support moving toward analyte-specific fasting guidance rather than a one-size-fits-all approach, potentially making preventive lab work more convenient — particularly for older adults managing chronic disease and metabolic health monitoring.
Detailed Summary
Routine blood testing has long required patients to fast for at least 8 hours beforehand, based on the assumption that food intake introduces unwanted variation in lab results. A major new study challenges whether that blanket rule is actually necessary for most tests.
Published in JAMA Internal Medicine, the cross-sectional study analyzed paired within-person blood draws from over 100,000 patients — mostly older adults at a single center in South Korea. Researchers examined 372 separate lab test items and compared results based on fasting duration: less than 8 hours, 8–12 hours, and more than 12 hours.
The core finding: the vast majority of tests showed no clinically significant difference based on fasting duration. Only a small subset of analytes exceeded established analytical performance specifications with shorter fasting. Glucose levels were higher by roughly 13 mg/dL with less than 8 hours of fasting versus 8–12 hours. Triglycerides rose by about 17–20 mg/dL, gamma-glutamyl transferase by over 21 U/L, and lipase showed a notable spike compared to longer fasts. Importantly, lipid panels overall were not meaningfully improved by longer fasting, aligning with existing U.S. guidelines that already endorse nonfasting lipid profiles for most adults.
For diabetes monitoring, fasting plasma glucose remains important in specific contexts — particularly when HbA1c, which reflects average blood sugar over 2–3 months, is unreliable. Clinicians are advised to interpret short-fast glucose results with care.
An accompanying editorial from Copenhagen University Hospital reinforced the findings, calling them strong support for abandoning routine fasting requirements for most blood samples. The practical implication is significant: simpler lab protocols could improve patient adherence and make preventive health monitoring — central to longevity-focused care — more accessible. Caveats include the study's single-center Korean cohort, which limits broader generalizability.
Key Findings
- Out of 372 lab tests analyzed, only a few — including glucose and triglycerides — showed meaningful changes with shorter fasting.
- Fasting less than 8 hours raised glucose by ~13 mg/dL and triglycerides by ~17 mg/dL compared to 8–12 hour fasts.
- Lipid panels showed no significant improvement with longer fasting, supporting nonfasting cholesterol testing for most adults.
- Findings support analyte-specific fasting rules rather than a blanket 8-hour requirement for all blood tests.
- Fasting plasma glucose remains important for diabetes diagnosis in cases where HbA1c is unreliable.
Methodology
This is a news report summarizing a cross-sectional observational study published in JAMA Internal Medicine, a high-credibility peer-reviewed journal. The study used paired within-person analyses from over 100,000 patients, providing strong statistical power. An expert editorial from Copenhagen University Hospital accompanies the findings, adding independent validation.
Study Limitations
The study was conducted at a single center in South Korea and predominantly included older patients, limiting generalizability to other populations. As an observational cross-sectional design, it cannot establish causation or account for all confounders. Clinical guidelines should be consulted before changing individual fasting protocols, particularly for diabetes or dyslipidemia management.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: